NovaBay Pharmaceuticals (NBY) Q2 2023 Earnings

10AugConfirmed
Aug 22
Nov 22
Q1 2023
Q2 2023
-3.5
-2.52
-1.53
-0.55

Details

Expected EPS
-0.55
Actual EPS
-1.27
Surprise EPS
-0.72
Surprise Percent
+130.91%

Description

NovaBay Pharmaceuticals (NBY) has reported earnings of -1.27 per share for Q2 2023.

0 Comments

Share your thoughts